Presented by: Jean-Noel Billaud, PhD | Duration: 57:58 minutes

Jean-Noel Billaud, PhD, Principal Scientist, QIAGEN Bioinformatics, presents how our in silico solutions enabled us to analyze and identify the biological parameters involved in EEC tumor progression including signaling pathways, biological processes, and potential transcriptional drivers. Read More

Presented by: Dr. Rajini Rani Haraksingh, Ph.D | Duration: 54:56 minutes

Dr Rajini Rani Haraksingh of Stanford Medical School and Director at the Rare Genomics Institute demonstrates her approach to discovering disease-causing variation in the human genome using Ingenuity® Variant Analysis as a tool. Read More

Presented by: John A. Martignetti, M.D., Ph.D. and Garry Nolan Ph.D. | Duration: 1:03:20 minutes

Discover how intuitive web-based applications can help scientists quickly analyze and accurately interpret the biological meaning in their genomic data. In the last few years, researchers and clinicians have been faced with the challenge of how to effectively sort through … Read More

Presented by: Dr. Darryl Gietzen, Senior Field Applications Scientist, QIAGEN Silicon Valley (formally Ingenuity Systems, Inc.) | Duration: 34:11 minutes

Whether you are a new or experienced user of Ingenuity Variant Analysis, you will benefit from attending this Tips and Tricks presentation. This presentation will walk you through several scenarios and give tips on how to work more efficiently and … Read More

Presented by: Dr. Stuart Tugendreich, Scientific Director, IPA | Duration: 34:11 minutes

See the whole picture! Powerful functionality enables you to understand causal connections between molecules and diseases. This Fall 2103 release of QIAGEN’s Ingenuity Pathway Analysis (IPA) has exciting new capabilities which enable interactive visual exploration of causality between molecules and … Read More

Presented by: Ben Laufer, PhD Candidate, Western University, Ontario, Canada | Duration: 54:54 minutes

Fetal alcohol spectrum disorders (FASDs) are characterized by life-long changes in gene expression, neurodevelopment and behavior. What mechanisms initiate and maintain these changes are not known, but current research suggests a role for alcohol-induced epigenetic changes. We assessed alterations to … Read More

Presented by: Dr. Ramon Felciano, Co-founder and Senior Vice President, Applied Research and Partnering, QIAGEN Silicon Valley | Duration: 50:33 minutes

Knowledge of immune system and host-pathogen pathways can inform development of targeted therapies and molecular diagnostics based on a mechanistic understanding of disease pathogenesis and the host response. We used QIAGEN’s Ingenuity platform to investigate the feasibility of rapid target … Read More

Presented by: Dr. Aaron Erdely, Health Effects Laboratory Division, NIOSH and Kaushal Parekh, Associate Staff Ontology Engineer, QIAGEN Silicon Valley | Duration: 36:55 minutes

Metal-rich particulate matter inhalation exposure results in target organ toxicity but also adverse systemic effects including cardiovascular dysfunction and immunosuppression. As a preliminary search for induction of systemic mechanisms, generation of comprehensive transcriptome datasets by DNA microarray, along with gene … Read More

Presented by: Dr. Stuart Tugendreich, Scientific Director, IPA | Duration: 48:24 minutes

The 2013 IPA Spring Release is here! Powerful new functionality enables you to upload, find, and compare datasets, and understand causal connections between diseases, genes, and networks of upstream regulators. Stuart Tugendriech, PhD, Scientific Director, IPA from QIAGEN Silicon Valley … Read More

Presented by: Gustavo Glusman, Senior Research Scientist, Institute for Systems Biology | Duration: 37:32 minutes

This webinar discusses the analysis of whole genome sequence data in Alternating Hemiplegia of Childhood (ACH) samples using custom workflows and QIAGEN’s Ingenuity Variant Analysis platform to improve the sensitivity and specificity of genome interpretation.